Global Intravascular Catheters Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2022 –2029 |
Market Size (Base Year) |
USD 557.30 Million |
Market Size (Forecast Year) |
USD 1,135.14 Million |
CAGR |
|
Major Markets Players |
全球血管内导管市场,按产品(短 PIVC 导管和集成/封闭 PIVC 导管)、应用(肾脏疾病、癌症、胃肠道疾病、传染病和其他疾病)、最终用户(医院、诊所、门诊手术中心、家庭护理和其他)划分 - 行业趋势和预测到 2029 年。
市场分析和规模
血管内超声 (IVUS)是一种诊断程序,可让医生实时查看冠状动脉。IVUS 是一种基于导管的医学成像程序,可让医生确定狭窄的严重程度,即动脉变窄或增厚的程度。该过程可产生管腔、动脉内部和动脉粥样硬化(即埋在动脉壁内的膜或富含胆固醇的白细胞)的可见图像。
Data Bridge Market Research 分析,血管内导管市场规模在 2021 年为 5.573 亿美元,到 2029 年将飙升至 11.3514 亿美元,预计在 2022 年至 2029 年的预测期内复合年增长率为 9.30%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
市场定义
血管内超声导管是一种用于评估冠状动脉和外周动脉血管形态的成像导管。它显示此类血管的横截面照片。它有一个圆柱形超声换能器阵列,可将声能发射到周围组织并测量由此产生的超声回声。
报告范围和市场细分
报告指标 |
细节 |
预测期 |
2022 至 2029 年 |
基准年 |
2021 |
历史岁月 |
2020(可定制至 2019 - 2014) |
定量单位 |
收入(百万美元)、销量(单位)、定价(美元) |
涵盖的领域 |
产品(短 PIVC 导管和集成/封闭 PIVC 导管)、应用(肾病、癌症、胃肠道疾病、传染病和其他疾病)、最终用户(医院、诊所、门诊手术中心、家庭护理和其他) |
覆盖国家 |
北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。 |
涵盖的市场参与者 |
Abbott (U.S), BD (U.S), Boston Scientific Corporation (U.S), Medtronic (Ireland), Cook (U.S), Johnson & Johnson Private Limited (U.S), Smith & Nephew plc (Germany), Cardinal Health (U.S), Terumo Corporation (Japan), Conavi Medical (U.S), Edwards Lifesciences Corporation (U.S), Infraredx, Inc. (U.S), Getinge AB (Sweden), Coloplast Corp (Denmark), McKesson Medical-Surgical (U.S) |
Market Opportunities |
|
Intravascular Catheters Market Dynamics
Drivers
- Growing incidence of Diseases
According to the World Health Organization (WHO), cancer is the second biggest cause of death worldwide. In 2018, cancer claimed the lives of more than 9.6 million people around the world. The growing usage of catheters for minimally invasive diagnostic and treatment procedures and the rising hospitalization rate due to the high incidence of chronic diseases are likely to fuel market growth.
- Low cost and easy insertion technique
The product segment for intravascular catheters is dominated by short PIVC. Healthcare providers use short PIVC due to its inexpensive cost and simple insertion technique in approved sites such as the wrist or antecubital vein. The frequent movement of the inserted needle, which causes phlebitis, infiltration, and dislodgment, bringing agony and anguish to the sick patient, is a constraint linked with short PIVC. Because of its intrinsic features, such as an enhanced stabilization frame that lowers inserted catheter movement and eliminates the need for additional securement devices, integrated PIVC is gaining a lot of traction. The use of an integrated PIVC has reduced the incidence of phlebitis and bloodstream infections caused by catheters (CABSI).
- Growing demand for minimal invasive surgical procedures pertaining to trauma incidence
According to the World Health Organization (WHO), 17.9 million people die each year as a result of cardiovascular problems around the world. Scientists believe that early surgical intervention can help to reduce this high mortality rate, which accounts for 31% of all fatalities worldwide. The other applications market is growing due to rising demand for minimally invasive surgical treatments for cardiovascular disease and trauma patients.
- Rising prevalence of hospital-acquired infection and existence of sophisticated healthcare infrastructure
North America now owns a 32% market share and is the clear leader in the intravascular catheters market in the regional sector. The increased prevalence of hospital-acquired infections and the presence of advanced healthcare infrastructure are two significant factors contributing to its market domination. Due to advantageous reimbursement scenarios for intravascular catheters and a considerable increase in the number of impatient procedures conducted to treat chronic diseases, Europe is currently in second place in the regional segment with a 30% share.
Opportunities
The governments of each country have enacted various laws and regulations in order to give medical coverage to millions of people. Over the forecast period of 2022 to 2029, programs like as the Child Health Insurance Program in the United States (CHIP), which provides low-cost coverage for youngsters and, in some cases, pregnant women, will contribute to the market's growth. The infectious diseases segment would expand the most due to the rising incidence of infectious diseases such as HIV, TB, and HPV. Hospital admissions and healthcare providers will undoubtedly grow as these diseases become more common. Intravascular catheters will be in high demand as a result of this.
Restraints/Challenges
The risk of bloodstream infections associated with intravascular catheter use and a scarcity of competent healthcare workers are two main factors limiting the worldwide intravascular catheters market's growth and, also because of high cost associated with the intravascular catheters.
This intravascular catheters market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the intravascular catheters market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Intravascular Catheters Market
Due to the COVID-19 pandemic, the demand for intravascular ultrasound (IVUS) devices has enlarged. According to the American College of Cardiology (ACC), around 40% of the COVID-19 recovered patients develop cardiovascular conditions. North America and Asia Pacific regions are the major contributors to the market growth owed to a few factors such as the increase in the need of IVUS actions during PCI procedures and the increase in the acceptance of IVUS systems in hospitals and diagnostic centers.
Global Intravascular Catheters Market Scope
血管内导管市场根据产品、应用和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。
产品
- 短外周静脉
- 集成/封闭式 PIVC
应用
- 肿瘤学
- 胃肠病学
- 肾脏疾病
- 传染病
- 其他的
终端用户
- 医院
- 诊所
- 门诊手术中心
- 家庭护理环境
- 其他的
血管内导管市场区域分析/见解
对血管内导管市场进行了分析,并按国家、产品、应用和最终用户提供了市场规模见解和趋势,如上所述。
血管内导管市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
预计亚太地区将在预测期内呈现最大增长。印度和中国等亚太地区发展中经济体的医疗支出和医疗旅游业的不断增长是该地区血管内导管市场增长的主要推动力。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
血管内导管市场还为您提供每个国家/地区资本设备医疗支出增长、血管内导管市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对血管内导管市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。
竞争格局和血管内导管市场份额分析
血管内导管市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对血管内导管市场的关注有关。
血管内导管市场的一些主要参与者包括:
- 雅培(美国)
- BD(美国)
- 波士顿科学公司 (美国)
- 美敦力(爱尔兰)
- 库克(美国)
- 强生私人有限公司(美国)
- Smith & Nephew plc(德国)
- 康德乐 (美国)
- 泰尔茂株式会社 (日本)
- Conavi Medical(美国)
- 爱德华生命科学公司(美国)
- Infraredx, Inc.(美国)
- Getinge AB(瑞典)
- 康乐保公司(丹麦)
- McKesson Medical-Surgical(美国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.